% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Roush:888724,
author = {Roush, David and Asthagiri, Dilip and Babi, Deenesh K. and
Benner, Steve and Bilodeau, Camille and Carta, Giorgio and
Ernst, Philipp and Fedesco, Mark and Fitzgibbon, Sean and
Flamm, Matthew and Griesbach, Jan and Grosskopf, Tobias and
Hansen, Ernst B. and Hahn, Tobias and Hunt, Stephen and
Insaidoo, Francis and Lenhoff, Abraham and Lin, Jasper and
Marke, Henrik and Marques, Bruno and Papadakis, Emmanouil
and Schlegel, Fabrice and Staby, Arne and Stenvang, Marcel
and Sun, Larry and Tessier, Peter M. and Todd, Robert and
Lieres, Eric and Welsh, John and Willson, Richard and Wang,
Gang and Wucherpfennig, Thomas and Zavalov, Oleksandr},
title = {{T}oward in silico {CMC}: {A}n industrial collaborative
approach to model‐based process development},
journal = {Biotechnology $\&$ bioengineering},
volume = {117},
number = {12},
issn = {1097-0290},
address = {New York, NY [u.a.]},
publisher = {Wiley},
reportid = {FZJ-2020-05159},
pages = {3986-4000},
year = {2020},
abstract = {The Third Modeling Workshop focusing on bioprocess modeling
was held in Kenilworth, NJ in May 2019. A summary of these
Workshop proceedings is captured in this manuscript.
Modeling is an active area of research within the
biotechnology community, and there is a critical need to
assess the current state and opportunities for continued
investment to realize the full potential of models,
including resource and time savings. Beyond individual
presentations and topics of novel interest, a substantial
portion of the Workshop was devoted toward group discussions
of current states and future directions in modeling fields.
All scales of modeling, from biophysical models at the
molecular level and up through large scale facility and
plant modeling, were considered in these discussions and are
summarized in the manuscript. Model life cycle management
from model development to implementation and sustainment are
also considered for different stages of clinical development
and commercial production. The manuscript provides a
comprehensive overview of bioprocess modeling while
suggesting an ideal future state with standardized
approaches aligned across the industry.},
cin = {IBG-1},
ddc = {570},
cid = {I:(DE-Juel1)IBG-1-20101118},
pnm = {583 - Innovative Synergisms (POF3-583)},
pid = {G:(DE-HGF)POF3-583},
typ = {PUB:(DE-HGF)16},
pubmed = {32725887},
UT = {WOS:000563627400001},
doi = {10.1002/bit.27520},
url = {https://juser.fz-juelich.de/record/888724},
}